Tag: treximet

Regulators seem all too happy to license ever more dangerous variations or combinations of older drugs already on the market and causing serious problems. This willingness has offered an opening for financial speculators to make a killing speculating on the likely profits these drugs could yield, and getting out of the game before much happens.